October 29, 2025

H-1B Visa Changes: Who Pays the Price?

New fee structure could hit hardest where physicians are needed most.

Conexiant

October 21, 2025

Can Cancer Bring America Together?

At a time of deep division, cancer survivors from across the political spectrum unite in Washington to demand action on research and care.

KFF Health News

October 06, 2025

Can Nicotinamide Reduce the Risk of Skin Cancer Development?

A retrospective study aimed to determine the clinical efficacy of nicotinamide supplementation for skin cancer prevention in the general population and among solid organ transplant recipients.

The ASCO Post

October 02, 2025

Nicotinamide Use Reduces SCC in Veterans With Prior Skin Cancer

Veterans were prescribed nicotinamide twice daily following prior skin cancer.

Conexiant

July 02, 2024

Black Docs Lacking Amid Growing Attacks on Diversity Programs

Research has shown that patients of color prefer seeing doctors of their own race — and some studies have shown health outcomes are better for Black patients seeing Black doctors.

KFF Health News

March 14, 2025

HPV Vaccine Reduces Actinic Keratoses

VAXAK randomized trial demonstrates significant reduction in precancerous skin lesions following standard 9-valent alphapapillomavirus vaccination.

Conexiant

August 13, 2024

Cancer Cases Among Men Projected to Soar 84% Globally by 2050

A population-based study including data from 185 countries revealed disparities in cancer incidence, mortality, and survival among men worldwide in 2022, with projections indicating a widening gap by 2050.

Conexiant

July 26, 2024

Healing and Owing: U.S. Health Workers' $150 Billion Debt Dilemma

A new study exposes the alarming levels of medical and educational debt burdening U.S. health care workers, with debt disproportionately affecting women, Black workers, and those in lower-paying fields.

Conexiant

February 17, 2025

Physician Turnover After Private Equity Exits

Researchers found physicians in private equity-exiting practices were less likely to stay and more likely to join larger groups within 2 years.

Conexiant